We plan to invest Rs 200 crore in the medicity facility coming up in Gurgaon, another Rs 200 crore towards…
Barely weeks after the government took note of the London-based International Policy Network report that pronounced India as one of…
The central government?s move to centralise WHO certification of pharmaceutical products for export has hit a roadblock, with the Madras…
An international UNAIDS delegation, led by UNAIDS executive director Michel Sidibe, arriving next week, is likely to discuss matters relating…
Within months of Apollo Hospitals bringing in cutting-edge cancer technology, “cyberknife”, to India, healthcare group Max Healthcare has introduced state-of-the-art…
Analjit Singh promoted corporate hospital chain Max Healthcare plans to add 1,200 beds in the next two years, taking its…
The Indian arm of the world?s third-largest biotech company, Genzyme India, is in initial talks with the Indian Council of…
The department of pharma is planning to set up Indian pharmacy chains in Nigeria to combat the damage that China-made…
The Centre has identified four institutions for developing shikimic acid, the basic raw material used for making swine flu drug…
Even with an investment of $86 billion (Rs 3.7 lakh crore) over the next 15 years, India would not be…
The government has managed to convince three international swine flu vaccine developers?Swiss firm Novartis, US-based Baxter and UK headquartered GSK…
Biocon Ltd, the Rs 1,600-crore biotech firm, has locked horns with the drug price regulator, the National Pharmaceutical Pricing Authority,…
Drug manufacturers are apprehensive that the recent amendment to the Drug and Cosmetic Act may be misused by state drug…
The swine flu vaccine developers in the country are seeking clarity on procurement strategy of the government to finalise their…
The world’s third largest biotech company, Massachusetts-based Genzyme Corporation, plans to launch three products in the Indian market next year.
The Drug Controller General of India has decided to centralise the issuance of WHO certificate of pharmaceutical product starting next…
A report prepared by the London-based International Policy Network (INP) could be greatly responsible for shaping the anti-Indian generics policy…
The Centre has asked international vaccine makers of swine flu, to conduct at least a part of their clinical trials…
